Taylor & Francis

Journal of Drug Assessment Template

Write in a clean editor, then format for Journal of Drug Assessment in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Journal of Drug Assessment format

Journal of Drug Assessment is a peer-reviewed journal published by Taylor & Francis, covering Medication Adherence and Compliance, Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical studies and practices.

PublisherTaylor & Francis
Reference styleAuthor–year (Chicago, T&F)
Author–year — (Smith, 2023) in the text
Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Journal of Drug Assessment 12 (3): 45–58.

Formats any DOI in Journal of Drug Assessment style. No sign-up.

Publishes research inMedication Adherence and Compliance Health Systems, Economic Evaluations, Quality of Life Pharmaceutical studies and practices Pharmaceutical Practices and Patient Outcomes Pharmaceutical Economics and Policy
ISSN2155-6660
h-index25
i10-index62
Total citations2,204
Article processing charge$969
Top institutions publishing hereHamad Medical Corporation
Journal websitewww.tandfonline.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Journal of Drug Assessment per year

2
2011
9
2012
16
2013
7
2014
5
2015
6
2016
5
2017
39
2018
73
2019
26
2020
10
2021
4
2022

Citation impact of Journal of Drug Assessment by publication year

10
2011
28
2012
252
2013
102
2014
30
2015
40
2016
78
2017
173
2018
720
2019
590
2020
121
2021
48
2022

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Journal of Drug Assessment

Epidemiology of atopic dermatitis in Europe

Elżbieta Kowalska-Olędzka, Magdalena Czarnecka, Anna Baran · 1 Jan 2019

Atopic dermatitis (AD) is a chronic inflammatory disease persisting predominantly in the pediatric population. Its development is most presumably multifactorial and a derivative of interplay between genetic, immunologic, and environmental causes. To the authors' knowledge, no multinational and systematic database of AD prevalence is established and maintained for Europe. Thus, epidemiologic data originating from the…

Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates

Müberra Devrim Güner, Perihan Elif Ekmekçi · 1 Jan 2019

Background: Spontaneous adverse drug reaction (ADR) reports prepared by healthcare professionals (HCPs) are the backbone of collecting post-marketing safety data. However, underreporting is a global problem creating health, economic, and ethical burden.Objectives: To determine the factors limiting ADR reporting rates from the HCPs’ point of view.Methods: A questionnaire containing 43 questions evaluating sociodemographic characteristics, pharmacovigilance…

Delivery characteristics of a low-resistance dry-powder inhaler used to deliver the long-acting muscarinic antagonist glycopyrronium

Paul Colthorpe, Thomas Voshaar, Thomas Kieckbusch et al. · 1 Feb 2013

OBJECTIVES: The long-acting muscarinic antagonist (LAMA) glycopyrronium (NVA237) has recently been approved as a once-daily treatment for COPD. The objectives of this study were to determine the dose delivery characteristics of glycopyrronium and compare them with those of the LAMA tiotropium, both delivered by their respective capsule-based dry-powder inhalers (DPIs). RESEARCH DESIGN AND METHODS: Seven…

Translation and validation of the English version of the general medication adherence scale (GMAS) in patients with chronic illnesses

Atta Abbas Naqvi, Mohamed Azmi Hassali, Amnah Jahangir et al. · 1 Jan 2019

Objective: This study aimed to translate the General Medication Adherence Scale (GMAS) into English language and validate it in patients suffering from chronic illnesses.Methods: A 1-month study (January 2018) was conducted in a random sample of patients suffering from chronic illnesses who visited the outpatient departments of four tertiary healthcare facilities in Karachi, Pakistan. Translation…

Journal of Drug Assessment template — frequently asked questions

How do I write a paper in the Journal of Drug Assessment format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Journal of Drug Assessment template. When you export, DocuGuru compiles the paper into the official Taylor & Francis format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Journal of Drug Assessment use?
Journal of Drug Assessment uses Author–year (Chicago, T&F) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Journal of Drug Assessment 12 (3): 45–58.
Do I need to know LaTeX to submit to Journal of Drug Assessment?
No. DocuGuru generates the interact LaTeX class and compiles the PDF for you in the background, so you get a Taylor & Francis-ready Journal of Drug Assessment document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Journal of Drug Assessment template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Journal of Drug Assessment format with correct headings, figures, tables, and author–year citations.
Who publishes Journal of Drug Assessment?
Journal of Drug Assessment is a multidisciplinary journal published by Taylor & Francis. DocuGuru's Journal of Drug Assessment template matches Taylor & Francis's official submission format.
Can I export a submission-ready Journal of Drug Assessment PDF?
Yes — DocuGuru produces a PDF built with the official Journal of Drug Assessment template (the interact class) that is ready to submit to Taylor & Francis, together with the matching LaTeX source files.
How much does the Journal of Drug Assessment template cost?
You can start writing in the Journal of Drug Assessment template for free. Exporting the final submission-ready Journal of Drug Assessment PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Journal of Drug Assessment template